18 results
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
comparison between SGLT ... -2 inhibitors - ... Canagliflozin ( ... Invokana) - Dapagliflozin ... (Steglatro) #diabetes
Indications for and pharmacological properties of approved SGLT2 inhibitors

Canagliflozin - Dapagliflozin - Empagliflozin - Ertugliflozin

#SGLT2 #Inhibitors
Indications for ... inhibitors Canagliflozin ... - Dapagliflozin ... - Empagliflozin ... Ertugliflozin #SGLT2
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
inhibitors in CVD ... CANVAS - Canagliflozin ... DECLARE-TIMI 58 - Dapagliflozin ... DAPA-CKD - Dapagliflozin ... DAPA-HF - Dapagliflozin
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Diabetes Combination ... Invokamet (metformin + canagliflozin ... Xigduo (metformin + dapagliflozin ... ) Dpp4 + SGLT2 ... ) • Qtern (dapagliflozin
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
SGLT2 inhibitors ... SGLT2 inhibitors ... treatment of type II diabetes ... (Invokana®), dapagliflozin ... , #dapagliflozin
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... gliflozin): • Empagliflozin ... the three • Dapagliflozin ... • Euglycemic diabetic ... #Summary #DM2 #diabetes
Summary of Diuretic Agents 
Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction
CARBONIC ANHYDRASE
Acetazolamide, others SGLT2 ... Canagliflozin ... • Dapagliflozin, ... empagliflozin ... #Diuretics #Medications
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Action for Common Diabetes ... Medications ... • SGLT2i (Dapagliflozin ... sarahthelyon #Diabetes ... #Medications #pharmacology
#diabetes #T2DM #antidiabeticagents #oraldiabeticagents

FIGURE 9.1 Glucose-lowering medication in type 2 diabetes: overall approach. For appropriate context,
Glucose-lowering medication ... the Effects of Canagliflozin ... dipeptidyl peptidase 4 inhibitor ... receptor agonist; SGLT2i ... , SGLT2 inhibitor
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... SGLT2 inhibitors ... class of anti-diabetic ... medications, with ... the first one (Canagliflozin